Kornelia Schlombs

Title: Kornelia Schlombs: Innovator in T Cell Detection Technology

Introduction

Kornelia Schlombs is a prominent inventor based in Wuppertal, Germany. She has made significant contributions to the field of immunology, particularly in the detection and quantification of T cell populations. Her innovative work has led to the development of a patented method that enhances the understanding of immune responses.

Latest Patents

Kornelia Schlombs holds a patent for a method titled "Method for detection, differentiation and quantification of T cell populations by way of reverse transcription quantitative real time PCR (RT-qPCR) technology." This invention involves a systematic approach to detect and differentiate T cell populations through a series of steps, including the use of antigen presenting cells and specific markers. The method allows for precise quantification of T cell populations, which is crucial for various medical applications.

Career Highlights

Kornelia Schlombs is associated with Lophius Biosciences GmbH, where she applies her expertise in immunology and molecular biology. Her work at the company focuses on advancing diagnostic technologies that can improve patient outcomes. With her innovative approach, she has positioned herself as a key figure in the field of T cell research.

Collaborations

Kornelia has collaborated with notable colleagues, including Ludwig Deml and Sascha Barabas. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of their research.

Conclusion

Kornelia Schlombs is a trailblazer in the field of T cell detection technology. Her patented method represents a significant advancement in immunological research, showcasing her dedication to innovation and collaboration in science.